NEW YORK (dpa-AFX) – After the recent recovery rally, investors on the US stock exchanges should take it easy for the time being in the middle of the week. Broker IG appraised the leading index Dow Jones Industrial around three quarters of an hour before the start of trading 0.21 percent higher to 35,794 points and the technology-heavy Nasdaq 100 
0.05 percent up to 16,334 points.
Statements by the pharmaceutical giant Pfizer and its Mainz partner Biontech proved to be a support for the course. Accordingly, the common corona vaccine against the new coronavirus variant Omikron is less effective than against previous variants. With three doses – i.e. after a vaccination booster – a similar neutralizing effect was shown, as with two doses with the original type of the virus.
While the Pfizer stocks themselves then gained more than one percent before the IPO and are likely to build on their previous day’s recovery, the shares of Biontech listed in New York even went up by a good three and a half percent. Shares of the Biontech competitor Moderna gained about half a percent before the market.
The shares of the online broker Robinhood showed a further recovery of a good two and a half percent after they had slipped to the lowest level in the company’s stock market history, which was just over four months old, on Monday.
– .
